Commonwealth Equity Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Buy |
260,565
+9,996
| +4% | +$429K | 0.02% | 828 |
|
|
2026
Q1 | $9.21M | Buy |
250,569
+19,109
| +8% | +$905K | 0.01% | 927 |
|
|
2025
Q4 | $11.8M | Sell |
231,460
-6,518
| -3% | -$333K | 0.02% | 813 |
|
|
2025
Q3 | $13.2M | Sell |
237,978
-237,049
| -50% | -$13.9M | 0.02% | 763 |
|
|
2025
Q2 | $32.8M | Buy |
475,027
+95,756
| +25% | +$6.51M | 0.04% | 412 |
|
|
2025
Q1 | $26.3M | Sell |
379,271
-29,565
| -7% | -$2.44M | 0.04% | 454 |
|
|
2024
Q4 | $35.2M | Sell |
408,836
-20,497
| -5% | -$2.22M | 0.05% | 343 |
|
|
2024
Q3 | $51.1M | Sell |
429,333
-76,659
| -15% | -$10.2M | 0.08% | 237 |
|
|
2024
Q2 | $72.2M | Buy |
505,992
+97,209
| +24% | +$12.9M | 0.11% | 163 |
|
|
2024
Q1 | $52.5M | Buy |
408,783
+172,206
| +73% | +$20.5M | 0.09% | 219 |
|
|
2023
Q4 | $24.5M | Buy |
236,577
+40,524
| +21% | +$4.01M | 0.04% | 395 |
|
|
2023
Q3 | $17.8M | Buy |
196,053
+6,965
| +4% | +$614K | 0.04% | 452 |
|
|
2023
Q2 | $15.3M | Buy |
189,088
+25,418
| +16% | +$2.08M | 0.03% | 509 |
|
|
2023
Q1 | $13K | Buy |
163,670
+8,612
| +6% | +$611K | 0.03% | 555 |
|
|
2022
Q4 | $10.5M | Sell |
155,058
-1,112
| -0.7% | -$65.2K | 0.03% | 610 |
|
|
2022
Q3 | $7.78M | Buy |
156,170
+1,024
| +0.7% | +$54.9K | 0.02% | 684 |
|
|
2022
Q2 | $8.64M | Sell |
155,146
-17,256
| -10% | -$958K | 0.02% | 639 |
|
|
2022
Q1 | $9.57M | Sell |
172,402
-2,266
| -1% | -$116K | 0.02% | 642 |
|
|
2021
Q4 | $9.78M | Sell |
174,668
-4,392
| -2% | -$238K | 0.02% | 608 |
|
|
2021
Q3 | $8.6M | Sell |
179,060
-3,494
| -2% | -$169K | 0.02% | 619 |
|
|
2021
Q2 | $7.65M | Buy |
182,554
+1,572
| +0.9% | +$60.9K | 0.02% | 662 |
|
|
2021
Q1 | $6.1M | Buy |
180,982
+11,036
| +6% | +$393K | 0.02% | 687 |
|
|
2020
Q4 | $5.93M | Buy |
169,946
+11,200
| +7% | +$387K | 0.02% | 658 |
|
|
2020
Q3 | $5.51M | Buy |
158,746
+2,528
| +2% | +$84.3K | 0.02% | 619 |
|
|
2020
Q2 | $5.11M | Buy |
156,218
+1,884
| +1% | +$60.1K | 0.02% | 599 |
|
|
2020
Q1 | $4.64M | Sell |
154,334
-9,720
| -6% | -$289K | 0.02% | 577 |
|
|
2019
Q4 | $4.75M | Buy |
164,054
+18,948
| +13% | +$525K | 0.02% | 652 |
|
|
2019
Q3 | $3.75M | Sell |
145,106
-5,982
| -4% | -$151K | 0.02% | 681 |
|
|
2019
Q2 | $3.85M | Sell |
151,088
-53,094
| -26% | -$1.31M | 0.02% | 663 |
|
|
2019
Q1 | $5.34M | Buy |
204,182
+7,246
| +4% | +$178K | 0.02% | 533 |
|
|
2018
Q4 | $4.54M | Buy |
196,936
+6,928
| +4% | +$154K | 0.02% | 523 |
|
|
2018
Q3 | $4.48M | Sell |
190,008
-904
| -0.5% | -$22.1K | 0.02% | 575 |
|
|
2018
Q2 | $4.4M | Sell |
190,912
-2,072
| -1% | -$49.2K | 0.02% | 553 |
|
|
2018
Q1 | $4.75M | Sell |
192,984
-286
| -0.1% | -$7.51K | 0.03% | 495 |
|
|
2017
Q4 | $5.19M | Sell |
193,270
-10,166
| -5% | -$259K | 0.03% | 462 |
|
|
2017
Q3 | $4.9M | Sell |
203,436
-1,622
| -0.8% | -$36.7K | 0.03% | 450 |
|
|
2017
Q2 | $4.4M | Buy |
205,058
+38,464
| +23% | +$776K | 0.03% | 484 |
|
|
2017
Q1 | $2.85M | Buy |
166,594
+7,596
| +5% | +$132K | 0.02% | 590 |
|
|
2016
Q4 | $2.85M | Buy |
158,998
+33,742
| +27% | +$612K | 0.02% | 569 |
|
|
2016
Q3 | $2.6M | Buy |
125,256
+6,294
| +5% | +$156K | 0.02% | 569 |
|
|
2016
Q2 | $3.2M | Sell |
118,962
-4
| -0% | -$110 | 0.03% | 491 |
|
|
2016
Q1 | $3.22M | Sell |
118,966
-1,560
| -1% | -$41.8K | 0.03% | 472 |
|
|
2015
Q4 | $3.5M | Buy |
120,526
+11,512
| +11% | +$319K | 0.03% | 436 |
|
|
2015
Q3 | $2.96M | Buy |
109,014
+2,946
| +3% | +$83.4K | 0.03% | 463 |
|
|
2015
Q2 | $2.9M | Buy |
106,068
+180
| +0.2% | +$5.06K | 0.03% | 489 |
|
|
2015
Q1 | $2.83M | Sell |
105,888
-1,584
| -1% | -$36.5K | 0.03% | 496 |
|
|
2014
Q4 | $2.27M | Buy |
107,472
+3,770
| +4% | +$84.2K | 0.03% | 525 |
|
|
2014
Q3 | $2.47M | Buy |
103,702
+992
| +1% | +$22.8K | 0.03% | 486 |
|
|
2014
Q2 | $2.37M | Buy |
102,710
+10,944
| +12% | +$242K | 0.03% | 500 |
|
|
2014
Q1 | $2.1M | Buy |
91,766
+1,076
| +1% | +$22.9K | 0.03% | 506 |
|
|
2013
Q4 | $1.68M | Buy |
90,690
+1,650
| +2% | +$28.8K | 0.02% | 557 |
|
|
2013
Q3 | $1.51M | Buy |
89,040
+5,350
| +6% | +$90K | 0.02% | 548 |
|
|
2013
Q2 | $1.3M | Buy |
+83,690
| New | +$1.39M | 0.02% | 565 |
|
Other funds holding NVO
F
Commonwealth Equity Services's NVO Position: Q2 2026 in Review
Commonwealth Equity Services increased its Novo Nordisk (NVO) stake by 4% in Q2 2026, buying an estimated $429K and bringing the position to 260,565 shares worth $12.5M. The position accounts for 0.02% of the portfolio, ranked #828.
Commonwealth Equity Services first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $72.2M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Commonwealth Equity Services held 260,565 shares of Novo Nordisk worth $12.5M as of Q2 2026.
- Commonwealth Equity Services bought 9,996 Novo Nordisk shares in Q2 2026, an estimated $429K.
- Novo Nordisk made up 0.02% of Commonwealth Equity Services's portfolio in Q2 2026, its #828 holding.
- Commonwealth Equity Services first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Commonwealth Equity Services's Novo Nordisk position peaked at $72.2M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.